Fintec Global Berhad is a Malaysia-based investment holding company that specializes in technology incubation, equity portfolio management, glove manufacturing, and commercial financial services. Founded in 2007 and headquartered in Petaling Jaya, Selangor, Malaysia, the company was formerly known as Asia Bioenergy Technologies Berhad before adopting its current name in 2017. The group structures its operations across four primary business segments: Technology Incubation, Portfolio Investment, Glove Business, and Financial Services. Through its Technology Incubation segment, the company provides early-stage venture funding; research and development advisory; business networking facilitation; corporate strategy mentoring; and incubation management services to emerging technology enterprises. In its Portfolio Investment division, conducted through wholly-owned investment subsidiaries including Asiabio Capital Sdn Bhd and Fintec Global Ltd, the company engages in active trading, asset allocation, and strategic long-term investments in quoted equities listed on Bursa Malaysia and foreign capital markets such as the United States. Within the Glove Business division, operating via Fintec Glove Sdn Bhd, the company manufactures, trades, and distributes medical-grade nitrile examination gloves and personal protective healthcare equipment under the proprietary Medela brand; provides rubber glove dipping line design and installation; and leases industrial dipping machinery and ancillary production equipment. Under its Financial Services segment, the company operates as a licensed credit provider, offering corporate financing facilities; working capital financing; secured and unsecured term loans; and micro-lending solutions to retail and commercial clients. In recent corporate developments, Fintec Global Berhad completed a comprehensive capital reorganization involving a 30-to-1 share consolidation in May 2024 and a subsequent RM310 million share capital reduction in May 2025 to rationalize its equity base and eliminate accumulated losses. In addition, the group adjusted conversion terms for its Irredeemable Convertible Preference Shares (ICPS) and executed significant active portfolio restructuring with major recurring acquisitions and divestments of quoted securities spanning 2024 through 2026, while optimizing its glove production capacities and investment holdings to adapt to post-pandemic industry cycles.